Key Takeaways Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The company's strong cash flow supports continued dividend growth and business ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Trading at just 11 times forward earnings ... as depicted by the moving average convergence divergence and signal line chart. Pfizer's MACD line vs. Signal line Starting from early May, the ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

In conjunction with the Seagen acquisition, Pfizer shifted its oncology focus from chemically made small-molecule drugs to ...

Shares of Pfizer Inc. PFE rose 3.46% to $30.19 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.71% to 5,792.04 and ...

Pfizer's stock (PFE) surged more than 4% Monday ... "The stock has been held in check over the past year, trading between the mid $20s to low $30s and not doing much outside of a pretty tight ...